Article: Data mixed on anticholinergic use for COPD.(Pulmonary Medicine)

PHILADELPHIA -- Despite recent hints of danger, inhaled anticholinergic drugs remain a mainstay of treatment for many patients with chronic obstructive pulmonary disease.

Inhaled anticholinergic drugs such as ipratropium and tiotropium should not be used in patients with chronic obstructive pulmonary disease (COPD) who are also at high risk for cardiovascular disease complications. This high-risk group includes patients with a significant cardiac arrhythmia, a recent cardiovascular disease event, ischemic heart disease, or heart failure, Dr. R. Graham Barr said at the annual meeting of the American College of Chest Physicians. An inhaled anticholinergic drug ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!